Medidata Blog

June 2 Media Roundup

Reading Time: < 1 minute

Here’s what you missed in recent industry news. Follow us on Twitter and LinkedIn for the latest in how technology is transforming life sciences.

BYO apps for clinical trials? This new tech allows patients to report symptoms using their personal smartphones.

Like a fly in a spider web. Researchers at Harvard have a new theory about the cause of Alzheimer’s disease.

Regeneron has been named the new sponsor of 75-year-old, iconic Science Talent Search.

A new study shows biomarkers have potential to triple the likelihood of clinical trial success.

​Scientists at Insilico are using AI to look for new uses of drugs.

Drones are saving lives in one of the world’s poorest nations.

CRISPR is teaching us how a single cell becomes a complex animal.

The Mayo Clinic is set to create the world’s largest research biobank to drive President Obama’s Precision Medicine Initiative.

June 2016 is the first ever acute myeloid leukemia awareness month.

Researchers at the National University of Singapore are using 3-D printing to adjust medications in the name of personalized medicine.

Are virtual assistants the future of healthcare? Staff at Boston Children’s Hospital are working to bring Alexa, Amazon’s voice recognition software program, into the hospital. From pulling up medical records to helping patients remember their discharge instructions, this technology could help streamline hospital processes at every level.

Ever wonder how our 40 trillion cells come from one fertilized egg? This new DNA technique is tracing the lineage of cells.

Bye-bye, unnecessary lab tests. Major hospital systems are betting on predictive tech to diagnose faster.

Meet real-life X-Men whose gene mutations cause super strength, endurance and more.

CRISPR/Cas9 genome editing has captured the attention of everyone. The gene editing approach, notable for its simplicity and cheap cost, has the potential to transform the scientific landscape. We want to know – what are your thoughts on the future of CRISPR and gene editing?

 

Geeks Talk Clinical